EASL Clinical Practice Guidelines on prevention and management of bleeding and thrombosis in patients with cirrhosis
- PMID: 35300861
- DOI: 10.1016/j.jhep.2021.09.003
EASL Clinical Practice Guidelines on prevention and management of bleeding and thrombosis in patients with cirrhosis
Abstract
The prevention and management of bleeding and thrombosis in patients with cirrhosis poses several difficult clinical questions. These Clinical Practice Guidelines have been developed to provide practical guidance on debated topics, including current views on haemostasis in liver disease, controversy regarding the need to correct thrombocytopenia and abnormalities in the coagulation system in patients undergoing invasive procedures, and the need for thromboprophylaxis in hospitalised patients with haemostatic abnormalities. Multiple recommendations in this document are based on interventions that the panel feels are not useful, even though widely applied in clinical practice.
Copyright © 2021 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
Conflict of interest statement
Conflict of interest Please refer to the accompanying EASL disclosure forms for details.
Comment in
-
Bleeding risk and thrombosis in cirrhosis: a paradox with a need to address them.Hepatobiliary Surg Nutr. 2023 Jun 1;12(3):410-412. doi: 10.21037/hbsn-23-138. Epub 2023 May 8. Hepatobiliary Surg Nutr. 2023. PMID: 37351148 Free PMC article. No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical